Tel: 27-11-2749300 Fax: 27-86-6846785 Email: info@elevationbiotech.com
Physical Address: Elevation Biotech 8 Blackwood Road Parktown Johannesburg, 2193 Republic of South Africa
January 2010 Home-Base Biotech As H1N1 spread from continent to continent in 2009, there was growing concern over the severity of swine flu in Africa, due to its lack of accessible healthcare and affordable drugs. But without a homegrown H1N1 vaccine, African countries are forced to compete for limited stockpiles in the global market, going up against developed countries with millions of dollars to spend. As of yet, no African countries have been able to buy the vaccine for themselves, forcing them to rely on donations. Developed countries and international groups have offered to help, but as of December, no vaccines had yet reached the continent.
22 May 2009 Local biotechnology project receives R1m grant Biotechnology regional innovation centre LIFElab reports that it has received a R1-million grant from global nonprofit organisation the International Aids Vaccine Initiative, for its Elevation Biotech (EB) project.
20 May 2009 South Africa central to HIV research Elevation Biotech is working on identifying antigens that will prompt the body to produce antibodies capable of neutralizing the virus.
May 2009 Small but tenacious: South Africa's health biotech sector Nature Biotechnology article describes how despite a challenging business environment, entrepreneurial health biotech companies in South Africa are finding ways to succeed citing Elevation Biotech.
1 December 2008 Vaccine needed to bring an end to AIDS World AIDS Day, observed on December 1, is a sobering reminder for all, especially to us in South Africa, that the toll from AIDS continues to mount, with no end to the pandemic in sight.
13 October 2008 Elevation Biotech partners with global initiative for AIDS vaccine Local biotechnology company Elevation Biotech has entered into a partnership with the International AIDS Vaccine Initiative (IAVI) to pursue its research into developing a jab against the disease.
12 October 2008 Aids research gets massive cash boost Aids vaccine research in South Africa has received a multimillion-dollar boost. Elevation Biotech, a Johannesburg biotechnology firm, has been awarded a one-year grant - part of a $30-million (R276-million) allocation by the International Aids Vaccine Initiative for research into an Aids vaccine.
30 May 2008 Address by Deputy Minister Address by Deputy Minister Derek Hanekom during the Science and Technology Budget Vote, National Assembly, Parliament 30 May 2008.
04 April 2008 SA yet to gain on drug trials South Africa is one of the world's biggest sites for multi-million dollar clinical trials into hoped-for pharmaceutical products, yet the final drugs and profits go to foreign corporates.
October 2007 HIV drugs: local could be lekker South African biotechnology entrepreneurs predict that their companies could turn a profit one day by offering locally-made antiretroviral drugs. Grant Napier from Elevation Biotech in Parktown and David Walwyn of Arvir in Modderfontein both spoke at the Bio2Biz conference in Cape Town in September.
08 May 2007 South Africa moves towards a bio-economy "Our National System of Innovation identifies biotechnology as one of the key platforms from which to address our economic and social challenges. As a developing country, we recognise the role of this cross cutting technology with regard to poverty alleviation, improving health and environment," said Derek Hanekom, South African Deputy Minister of Science and Technology.
20 July 2007 The Quest for Immunity Two SA laboratories are investing millions of rand in HIV/Aids drug research in a quest to break into the antiretroviral manufacturing market, which will be worth R8bn annually by 2011 in SA alone, or US$7bn globally.